The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation

Heart Rhythm

Volumn 12, Issue 4, 2015, Pages 681-686

  Jacobs, Victoria ^a   May, Heidi T ^a   Bair, Tami L ^a   Crandall, Brian G ^a   Cutler, Michael ^a   Day, John D ^a   Weiss, J Peter ^a   Osborn, Jeffrey S ^a   Muhlestein, Joseph B ^a   Anderson, Jeffrey L ^a   Mallender, Charles ^a   Bunch, T Jared ^a  

^a INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

Ablation; Atria fibrillationablation; Atrial fibrillation; Diabetes; Heartfailure; Hypertension; Outcomes; Riskfactors; Stroke

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; TRANSIENT ISCHEMIC ATTACK; ADVERSE EFFECTS; ATRIAL FIBRILLATION; COMPARATIVE STUDY; METHODOLOGY; MIDDLE AGED; MORTALITY; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; STROKE; SURVIVAL; TIME; TREATMENT OUTCOME; UNITED STATES;

ANTICOAGULANT AGENT;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; STROKE; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84925300903     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.12.034     Document Type: Article

References (15)

1. A.A. Hussein, W.I. Saliba, and D.O. Martin Natural history and long-term outcomes of ablated atrial fibrillation Circ Arrhythm Electrophysiol 4 2011 271 278
2. A.N. Ganesan, N.J. Shipp, A.G. Brooks, P. Kuklik, D.H. Lau, H.S. Lim, T. Sullivan, K.C. Roberts-Thomson, and P. Sanders Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis J Am Heart Assoc 2 2013 e004549
3. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
4. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation Chest 137 2010 263 272
5. T.P. Van Staa, E. Setakis, G.L. Di Tanna, D.A. Lane, and G.Y. Lip A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice J Thromb Haemost 9 2011 39 48
6. R.A. Winkle, R.H. Mead, G. Engel, M.H. Kong, and R.A. Patrawala Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients Europace 16 2014 195 201
7. K.P. Letsas, M. Efremidis, G. Giannopoulos, S. Deftereos, L. Lioni, P. Korantzopoulos, K. Vlachos, S. Xydonas, C. Kossyvakis, and A. Sideris CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation Europace 16 2014 202 207
8. J. Kornej, G. Hindricks, J. Kosiuk, A. Arya, P. Sommer, D. Husser, S. Rolf, S. Richter, Y. Huo, C. Piorkowski, and A. Bollmann Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry Circ Arrhythm Electrophysiol 7 2014 281 287
9. J. Kornej, G. Hindricks, J. Kosiuk, A. Arya, P. Sommer, D. Husser, S. Rolf, S. Richter, Y. Huo, C. Piorkowski, and A. Bollmann Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry Circ Arrhythm Electrophysiol 6 2013 868 874
10. M.A. Crandall, B.D. Horne, J.D. Day, J.L. Anderson, J.B. Muhlestein, B.G. Crandall, J.P. Weiss, J.S. Osborne, D.L. Lappé, and T.J. Bunch Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors Pacing Clin Electrophysiol 32 2009 981 986
11. H.T. Tu, B.C. Campbell, A. Meretoja, L. Churilov, K.R. Lees, G.A. Donnan, and S.M. Davis Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation Cerebrovasc Dis 36 2013 273 280
12. A. Paoletti Perini, S. Bartolini, and P. Pieragnoli CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy Europace 16 2014 71 80
13. J.H. Svendsen, J.C. Nielsen, S. Darkner, G.V. Jensen, L.S. Mortensen, and H.R. Andersen DANPACE Investigators. CHADS2 and CHA2DS2-VASc score to assess risk of stroke and death in patients paced for sick sinus syndrome Heart 99 2013 843 848
14. G. Ntaios, G.Y. Lip, K. Makaritsis, V. Papavasileiou, A. Vemmou, E. Koroboki, P. Savvari, E. Manios, H. Milionis, and K. Vemmos CHADS(2), CHA(2)S(2)DS(2)-VASc, and long-term stroke outcome in patients without atrial fibrillation Neurology 80 2013 1009 1017
15. T.J. Bunch, B.G. Crandall, J.P. Weiss, H.T. May, T.L. Bair, J.S. Osborn, J.L. Anderson, J.B. Muhlestein, B.D. Horne, D.L. Lappe, and J.D. Day Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation J Cardiovasc Electrophysiol 22 2011 839 845